Sign in
Explore the registryTrack Atogepant 60 mg's trials

ELEVATE

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Atogepant 60 mgCompletedCompletedPhase 3Open NCT04740827 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…